Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Validation of the Revised International Prognostic Scoring System in 2582 Patients with Myelodysplastic Syndrome: A Multicenter Study By the Hellenic MDS Study Group

Athanasios Galanopoulos, MD PhD, Christos K. Kontos, Nora-Athina Viniou, MD PhD, Ioannis Kotsianidis, MD PhD, Vassiliki Pappa, MD PhD, Aleka Kourakli, MD PhD, Anastasia Pouli, Panayiotis Panayiotidis, MD PhD, Paraskevi Roussou, MD PhD, Kalliopi Zafeiropoulou, Stamatis Karakatsanis, Maria Dimou, Anna Vardi, Theodoros Vassilakopoulos, MD PhD, Dimitris Tsokanas, Eleftheria Hatzimichael, MD PhD, Aikaterini Megalakaki, MD, Georgia D Kaiafa, MD PhD, Menelaos Konstantinos Papoutselis, Anastasia Sioni, Nikolaos Charchalakis, MD PhD, Eleni Bouronikou, MD PhD, George Vassilopoulos, MD PhD, Vasilios Lazaris, Maria Spiliotopoulou, Panagiotis Theodorou Diamantopoulos, Flora Kontopidou, MD PhD, Zoi Topouzoglou, Stamatina Kalyva, Helen A. Papadaki, MD PhD, Apostolos I Hatzitolios, Professor of Internal MDcine, Achilles Anagnostopoulos, MD, Evangelos Briasoulis, MD PhD, Nikolaos I. Anagnostopoulos, MD, Argiris S. Symeonidis, MD PhD

Blood (2016) 128 (22): 2004.

https://doi.org/10.1182/blood.V128.22.2004.2004

Published: 2016

Journal Articles

Expression Profiling of a Panel of Apoptosis Related Micrornas in Patients with Acute Myeloid Leukemia

Eleftheria Hatzimichael, MD PhD, Aggeliki Dasoula, Maria Igglezou, Andreas Katsenos, Ioannis Sainis, Isidore Rigoutsos, Evangelos Briasoulis, MD PhD

Blood (2015) 126 (23): 4971.

https://doi.org/10.1182/blood.V126.23.4971.4971

Published: 2015

Journal Articles

Towards a Reference Human Platelet Transcriptome: Evaluation Of Inter-Individual Correlations and Its Relationship With a Platelet Proteome

Eric R. Londin, PhD, Eleftheria Hatzimichael, MD, PhD, Phillipe Loher, BS, Leonard C. Edelstein, PhD, Chad Shaw, PhD, Kathleen Delgrosso, MS, Paolo M. Fortina, MD, PhD, Paul F Bray, MD, Steven E. McKenzie, MD, PhD, Isidore Rigoutsos, PhD

Blood (2013) 122 (21): 2297.

https://doi.org/10.1182/blood.V122.21.2297.2297

Published: 2013

Journal Articles

Tissue Factor Pathway Inhibitor 2 ( TFPI2 ) Is Commonly Methylated in Multiple Myeloma

Eleftheria Hatzimichael, MD, PhD, Aggeliki Dasoula, Valentinos Kounnis, Andreas Katsenos, Tim Crook, Evangelos Briasoulis, MD, PhD

Blood (2012) 120 (21): 4617.

https://doi.org/10.1182/blood.V120.21.4617.4617

Published: 2012

Journal Articles

Beyond mRNAs and Mirnas: Unraveling the Full-Spectrum of the Normal Human Platelet Transcriptome Through Next-Generation Sequencing

Eric R. Londin, PhD, Eleftheria Hatzimichael, MD, PhD, Phillipe Loher, BS, Yue Zhao, PhD, Yi Jing, MD, PhD, Huang Chen, PhD, Leonard C. Edelstein, PhD, Srikanth Nagalla, MD, MS, Kathleen Delgrosso, MS, Adam Ertel, PhD, Joan Kupper, BS, Paolo M. Fortina, MD, PhD, Steven E. McKenzie, MD, PhD, Paul F. Bray, MD, Isidore Rigoutsos, PhD

Blood (2012) 120 (21): 3298.

https://doi.org/10.1182/blood.V120.21.3298.3298

Published: 2012

Journal Articles

Leptin and Adiponectin Blood Levels in Patients with Steady State Sickle Cell Disease Are Related to Chronic Hemolytic and Inflammatory Biomarkers

Alexandros Makis, Anna Challa, Freideriki Koutsouka, Eleftheria Hatzimichael, MD, PhD, Xanthi Pliakou, Evangelos Briasoulis, Antigone Siamopoulou, Nikolaos Chaliasos

Blood (2012) 120 (21): 1012.

https://doi.org/10.1182/blood.V120.21.1012.1012

Published: 2012

Journal Articles

Significant Improvement of the Survival of Patients with Multiple Myeloma Presenting with Severe Renal Impairment After the Introduction of Novel Agents

Meletios A Dimopoulos, MD, Sosana Delimpasi, Eirini Katodritou, Eleftheria Hatzimichael, MD, PhD, Marie-Christine Kyrtsonis, Panagiotis Repousis, Zafiris Kartasis, Agapi Parcharidou, Michalis Michael, Eurydiki Michalis, Dimitra Gika, Argiris Symeonidis, MD, PhD, Konstantinos Zervas, Evangelos Terpos, Efstathios Kastritis

Blood (2012) 120 (21): 948.

https://doi.org/10.1182/blood.V120.21.948.948

Published: 2012

Journal Articles

The Prolyl-3-Hydroxylase Leprecan Like 1 (Leprel1) Is a Selective Target for Epigenetic Silencing In Multiple Myeloma.

Eleftheria Hatzimichael, MD, PhD, Evangelia Xirofotou, Aggeliki Dasoula, Cristiana Lo Nigro, Laura Lattanzio, Marco Merlano, George Dranitsaris, Konstantinos Bourantas, Tim Crook

Blood (2010) 116 (21): 3645.

https://doi.org/10.1182/blood.V116.21.3645.3645

Published: 2010

NARROW

Validation of the Revised International Prognostic Scoring System in 2582 Patients with Myelodysplastic Syndrome: A Multicenter Study By the Hellenic MDS Study Group

Expression Profiling of a Panel of Apoptosis Related Micrornas in Patients with Acute Myeloid Leukemia

Towards a Reference Human Platelet Transcriptome: Evaluation Of Inter-Individual Correlations and Its Relationship With a Platelet Proteome

Tissue Factor Pathway Inhibitor 2 ( TFPI2 ) Is Commonly Methylated in Multiple Myeloma

Beyond mRNAs and Mirnas: Unraveling the Full-Spectrum of the Normal Human Platelet Transcriptome Through Next-Generation Sequencing

Leptin and Adiponectin Blood Levels in Patients with Steady State Sickle Cell Disease Are Related to Chronic Hemolytic and Inflammatory Biomarkers

Significant Improvement of the Survival of Patients with Multiple Myeloma Presenting with Severe Renal Impairment After the Introduction of Novel Agents

The Prolyl-3-Hydroxylase Leprecan Like 1 (Leprel1) Is a Selective Target for Epigenetic Silencing In Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only